People with myalgic encephalomyelitis continue to be at risk of following damaging advice provided by the NHS. This risk is fostered by core recommendations of Clinical Guideline 53 (relevant extracts enclosed); notably, advice to undertake graded exercise, whether with or without a cognitive component - i.e. CBT in the form of graded exercise, with patient ‘education’ as to why this is deemed suitable. Recommendation 1.9.3.1 on severely affected patients is also of concern in this regard.
As long ago as 2002 the Chief Medical Officer’s Working Group recognised that “substantial concerns exist regarding the potential for harm” in respect of graded exercise1 , and that patient reports “clearly indicate that the York review results do not reflect the full spectrum of patients’ experience2 .”
We do not consider that it is acceptable for this situation to continue unabated pending the publication of the revised guideline, presently scheduled for April 2021.
We are aware that the Health Department in Scotland has recently cautioned against graded exercise ‘therapy’ - see
https://tinyurl.com/y5txhdv9 (announcement Nov 2020) and
https://tinyurl.com/yyherfp5 (publication August 2020).
We call on the Department of Health to make a similar caution public now in order to help to safeguard patients in England.